FibroGen (FGEN) PT Raised to $72 at Mizuho Securities on Strong Ph3 MACE Data
Tweet Send to a Friend
Mizuho Securities analyst Difei Yang raised the price target on FibroGen (NASDAQ: FGEN) to $72.00 (from $65.00) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
